Healthtech funding in Q4 2013

European Healthtech startup funding raised during Q4 2013.

In Q4 2013, 30 European Healthtech companies closed 30 funding rounds and raised €187M in equity funding (excluding debt and grants), up 48.2% versus Q4 2012. Switzerland led by capital raised, and Capricorn Partners was the most active investor. Data as of 6 Nov 2026.

Equity funding

€187M

+48.2% vs Q4 2012 · excl. debt & grants

Funding rounds

+20.0% vs Q4 2012

Companies

Top country

Switzerland

Rank among sectors

11.5% of sector funding

Top-10 round share

92.9%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Oct	€100M	13
Nov	€77M	13
Dec	€10M	4

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q4 2013
Switzerland	€60M
France	€47M
UK	€35M
Netherlands	€31M
Belgium	€4.0M
Israel	€3.7M
Ireland	€3.0M
Austria	€1.0M

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q4 2013
Series B	€59M
Other	€53M
Series D+	€30M
Growth/Late	€30M
Early VC	€4.3M
Series A	€4.0M
Seed	€3.4M
Series C	€3.0M
Grant	€160k

Top deals

largest disclosed rounds in Q4 2013

Company	Stage	Date	Amount
Merus	Series B	Oct 2013	€31M
Biocartis	Series D+	Nov 2013	€30M
ADC Therapeutics	Growth/Late	Oct 2013	€30M
MISSION Therapeutics	Series B	Nov 2013	€24M
Pixium Vision	Other	Nov 2013	€15M
THERAVECTYS	Other	Oct 2013	€15M
Morria Biopharmaceuticals	Other	Oct 2013	€11M
Gecko Biomedical	Other	Dec 2013	€9.9M
TROD Medical	Series B	Oct 2013	€4.8M
iSTAR Medical	Series A	Nov 2013	€4.0M
CartiHeal	Early VC	Oct 2013	€3.7M
Opsona	Series C	Oct 2013	€3.0M
Bioaxial	Other	Nov 2013	€2.4M
Diagnosia	Seed	Oct 2013	€1.0M
Angiodroid	Seed	Oct 2013	€900k

View all 30 Healthtech deals in Q4 2013 →

Top investors

most active in Q4 2013, by deal count

← All 2013 Healthtech funding